“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
Reviews
There are no reviews yet.
Be the first to review “Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience” Cancel reply
Reviews
There are no reviews yet.